{
    "ticker": "SCPS",
    "name": "Scopus BioPharma Inc.",
    "description": "Scopus BioPharma Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cancer and other serious diseases. Founded in 2016, Scopus is dedicated to advancing its proprietary drug candidates through rigorous scientific research and clinical trials. The company's lead product candidate, SCY-078, is an oral antifungal compound currently being evaluated for its efficacy in treating various fungal infections and has shown promise in preclinical studies. Additionally, Scopus is exploring the application of its proprietary platform technology in other therapeutic areas, including immuno-oncology and autoimmune diseases. By leveraging cutting-edge science and a robust pipeline, Scopus aims to address significant unmet medical needs and improve patient outcomes. The company is committed to collaborating with leading research institutions and industry partners to accelerate the development of its therapies, ultimately striving to bring new hope to patients battling life-threatening conditions. Scopus BioPharma\u2019s mission is to create a transformative impact on global health through innovative biopharmaceutical solutions.",
    "industry": [
        "Biopharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "New York, New York, USA",
    "founded": "2016",
    "website": "https://www.scopusbiopharma.com",
    "ceo": "Ron Cohen",
    "social_media": {
        "twitter": "https://twitter.com/ScopusBioPharma",
        "linkedin": "https://www.linkedin.com/company/scopus-biopharma-inc/"
    },
    "investor_relations": "https://www.scopusbiopharma.com/investor-relations",
    "key_executives": [
        {
            "name": "Ron Cohen",
            "position": "CEO"
        },
        {
            "name": "Daniel Cohen",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Drug Candidates",
            "products": [
                "SCY-078"
            ]
        }
    ],
    "seo": {
        "meta_title": "Scopus BioPharma Inc. | Innovative Biopharmaceutical Solutions",
        "meta_description": "Explore Scopus BioPharma Inc., a clinical-stage biopharmaceutical company focused on developing therapies for cancer and serious diseases. Learn about our innovative drug candidates and commitment to patient care.",
        "keywords": [
            "Scopus BioPharma",
            "Biopharmaceuticals",
            "Cancer Treatment",
            "SCY-078",
            "Innovative Therapies"
        ]
    },
    "faq": [
        {
            "question": "What is Scopus BioPharma known for?",
            "answer": "Scopus BioPharma is known for developing innovative therapies for cancer and serious diseases, focusing on its lead drug candidate SCY-078."
        },
        {
            "question": "Who is the CEO of Scopus BioPharma?",
            "answer": "Ron Cohen is the CEO of Scopus BioPharma Inc."
        },
        {
            "question": "Where is Scopus BioPharma headquartered?",
            "answer": "Scopus BioPharma is headquartered in New York, New York, USA."
        },
        {
            "question": "What are Scopus BioPharma's main products?",
            "answer": "Scopus BioPharma's main product candidate is SCY-078, an oral antifungal compound."
        },
        {
            "question": "When was Scopus BioPharma founded?",
            "answer": "Scopus BioPharma was founded in 2016."
        }
    ],
    "competitors": [
        "AMGN",
        "BMY",
        "GILD",
        "MRNA"
    ],
    "related_stocks": [
        "PFE",
        "JNJ",
        "ABBV",
        "REGN"
    ]
}